Biomarker Changes and Anxiolytic Effects-Phase 2

NCT04565145 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Pharmacokinetics

Interventions

DRUG: Kava Dietary Supplement
DRUG: Placebo

Sponsor

University of Florida

Collaborators

[object Object]
[object Object]